Maged Shenouda, CFO at RELMADA THERAPEUTICS, INC. (RLMD), sold 3,000 shares at $31.59 ($96K) on 2021-01-27, disclosed to the SEC on 2021-01-29.
Open-market sale of $96k RLMD by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.59 | 1,800 | $57K | 59.4% |
| 2 | $32.43 | 1,200 | $39K | 40.6% |
| Total | $31.93 avg | 3,000 | $96K | 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $1.1M | — | Filing → |
| RLMD | BUY | 2025-05-20 | $97K | — | Filing → |
| RLMD | BUY | 2024-09-11 | $207K | — | Filing → |